| Marc W Diamond, MD | |
|
1524 Atwood Ave Suite 110, Atwood Pediatrics Inc, Johnston, RI 02919 | |
| (401) 274-2910 | |
| (401) 274-8907 |
| Full Name | Marc W Diamond |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1524 Atwood Ave Suite 110, Johnston, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487721148 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 7052 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marc W Diamond, MD 1524 Atwood Ave Suite 110, Johnston, RI 02919 Ph: (401) 274-2910 | Marc W Diamond, MD 1524 Atwood Ave Suite 110, Atwood Pediatrics Inc, Johnston, RI 02919 Ph: (401) 274-2910 |
News Archive
There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects. Unmet needs of patients, especially those with advanced melanoma are therefore quite high and have led to a low drug adoption and market growth over the years. The future looks brighter though, with a few promising drugs in pipeline for advanced melanoma.
The 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (MS) concluded today in London (September 14-17) and one of the late breaking sessions presented the Clinical Guideline on the pharmacological management of people with Multiple Sclerosis developed jointly by ECTRIMS and European Academy of Neurology (EAN).
Forest Laboratories, Inc. announced today that it has entered into an agreement with Morgan Stanley & Co. Incorporated to repurchase approximately $500 million of its common shares under an accelerated share repurchase program. Forest will acquire these common shares under the Board authorized 50 million share repurchase program announced on May 18, 2010.
Striatal dopamine transporter binding, assessed using single-photon emission computed tomography, is strongly correlated with substantia nigra cell counts assessed at postmortem, say the authors of a study.
› Verified 6 days ago
Dr. Gennaro Frank Pasquariello, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1524 Atwood Ave, Johnston, RI 02919 Phone: 401-274-2910 Fax: 401-274-8907 | |
Leonora First, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1524 Atwood Ave Suite 110, Johnston, RI 02919 Phone: 401-274-2910 Fax: 401-274-8907 | |
Rebecca M Friedman, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1126 Hartford Ave, Johnston, RI 02919 Phone: 401-351-2750 | |
Mr. John Anthony Sanacore, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1524 Atwood Ave, Suite 110, Johnston, RI 02919 Phone: 401-274-2910 Fax: 401-274-8907 | |
Vincent D'alessandro, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1857 Atwood Ave, Johnston, RI 02919 Phone: 401-231-3300 | |
Janis Lee Baccari, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1524 Atwood Ave, Suite 110, Johnston, RI 02919 Phone: 401-274-2910 Fax: 401-274-8907 |